Target intelligence / Profile preview

Rab15 effector protein (REP15)

Target
REP15
Molecular classification
Other (Rab effector protein)
01

Overview

Rab15 effector protein (REP15) is a compartment-specific effector that interacts with active (GTP-bound) Rab GTPases, primarily Rab15, and also Rab3 paralogs and Rab34[2][3]. REP15 localizes to the endocytic recycling compartment (ERC), where it colocalizes with Rab15 and Rab11, regulating the recycling of the transferrin receptor, a process essential for iron homeostasis and membrane trafficking. REP15 does not contain known functional or membrane domains seen in other Rab effectors and adopts a unique globular structure[1][2]. Functionally, manipulation of REP15 expression (either overexpression or knockdown) disrupts transferrin receptor recycling from the ERC without affecting the rapid recycling from sorting endosomes, highlighting its compartment specificity[1]. In glioblastoma cells, REP15 depletion impairs cell proliferation and migration, implying a potential but not yet fully defined role in oncogenesis[2][4]. No drugs are currently known to target REP15 directly, and there are no established mechanisms of drug action, biomarker utility, or specific therapeutic safety concerns associated with this protein. REP15's principal significance is as a basic cell biology regulator rather than a current clinical target.

Other names
Rab15 effector proteinREP15RAB15EP
02

Biological functions

Receptor recycling (specifically transferrin receptor)Endocytic traffickingRegulation of cell proliferationRegulation of cell migration
03

Disease associations

Cancer (due to role in cell proliferation and migration, supported by data on glioblastoma cells)

Beyond the preview

Go deeper on Rab15 effector protein (REP15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rab15 effector protein (REP15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call